Browsing: Conditions

Nontuberculous mycobacterial infections have become an increasing concern for people with chronic lung disease, in part because the infections can linger despite months of antibiotic treatment. Among the most common culprits is Mycobacterium avium, which can trigger persistent inflammation in the lungs and leave patients with ongoing symptoms even when antimicrobial therapy is underway

SOLANA BEACH, Calif. and AHMEDABAD, India and LONDON, Aug. 11, 2026 /PRNewswire/ — Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company and wholly-owned subsidiary of Zydus Lifesciences Limited (“Zydus”) and Mereo BioPharma Group plc (Nasdaq: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that they have entered into…

WHO has received a US$ 3 million grant from Wellcome to strengthen the generation and use of community evidence alongside epidemiological, clinical and laboratory data throughout the response to Bundibugyo virus disease (BVD). The investment will help ensure that operational decisions are also informed by evidence on how affected communities experience, understand and respond to…

Fla. (WCJB) – In this week’s Tech Tuesday, our partners at UF Innovate and SCAD Media feature the Center for Inflammation Science and Systems Medicine (CISSM), with Dr. Joe G.N. “Skip” Garcia, who discusses how the center is focused on developing new drugs to target and combat inflammatory diseases